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Abstract
Low back pain is an extremely common illness syndrome that causes patient suffering and disability and
requires urgent solutions to improve the quality of life of these patients. Treatment options aimed to regenerate
the intervertebral disc (IVD) are still under development. The cellular complexity of IVD, and consequently its
ﬁne regulatory system, makes it a challenge to the scientiﬁc community. Biomaterials-based therapies are the
most interesting solutions to date, whereby tissue engineering and regenerative medicine (TE&RM) strategies
are included. By using such strategies, i.e., combining biomaterials, cells, and biomolecules, the ultimate goal of
reaching a complete integration between native and neo-tissue can be achieved. Hydrogels are promising
materials for restoring IVD, mainly nucleus pulposus (NP). This study presents an overview of the use of
hydrogels in acellular and cellular strategies for intervertebral disc regeneration. To better understand IVD
and its functioning, this study will focus on several aspects: anatomy, pathophysiology, cellular and biomolecular
performance, intrinsic healing processes, and current therapies. In addition, the application of hydrogels as NP
substitutes will be addressed due to their similarities to NPmechanical properties and extracellular matrix. These
hydrogels can be used in cellular strategies when combined with cells from different sources, or in acellular
strategies by performing the functionalization of the hydrogels with biomolecules. In addition, a brief summary
of therapies based on simple injection for primary biological repair will be examined. Finally, special emphasiswill
focus on reviewing original studies reporting on the use of autologous cells and biomolecules such as platelet-rich
plasma and their potential clinical applications. Copyright © 2011 John Wiley & Sons, Ltd.
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1. Human spine and intervertebral
disc (IVD)
The human spine plays an important role in loading the
structures where the internal organs are attached support-
ing the superior part of the body and transmitting loads
between superior and inferior extremities (Pye et al.,
2007). Bodyweight andmuscle activity are themain factors
responsible for such loads on the spine. The protection of
the nerves along this structure is provided from the brain
to the periphery (arms and legs) (Bao et al., 1996; Kalson
et al., 2004; Shankar et al., 2009). Occupying one-third of
the spine height, the linked spine structure contains 24
intervertebral discs (IVDs) separating the bony vertebrae.
Body motion is controlled by the IVDs in three distinct
planes: lateral bending, axial rotation, and ﬂexion-
extension (Twomey and Taylor, 1985; Roberts et al., 1989).
IVD is a ﬁbrocartilaginous structure composed of three
morphologically distinct regions (nucleus pulposus, annu-
lus ﬁbrosus, endplates) working together to absorb and
disperse energy and transfer loads within the spine
(Nerurkar et al., 2010; Lotz et al., 2002). Simultaneously,
IVDs provide ﬂexibility, enabling movements such as
bending, ﬂexion, and torsion. During heavy lifting
activities, forces up to 17 kN have been estimated in
lumbar discs. All types of loads, mainly caused by
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torsion, can induce early degeneration in the disc
(Cholewicki et al., 1991).
The central gelatinous core of the IVD, the nucleus
pulposus (NP), is composed of 80% water during youth
and progressively loses water content throughout the
years (Coventry et al., 1945). Unlike other IVD regions,
the NP develops from endoderm. In adulthood, the NP
contains an amorphous matrix of proteoglycans (PGs)
positioned in a network of randomly organized collagen
(mainly type II) and elastin. The collagen crosslinking
provides form and tensile strength to the NP, whereas
the PGs (mainly aggrecan) maintain their viscoelastic
properties, resistance to compression, and stiffness, since
they sustain the osmotic pressure by which water enters
and nutrient exchange occurs. The capacity to absorb
and release water is related to the capacity to absorb
shocks (Walker and Anderson, 2004; Singh et al., 2009;
Woods et al., 2010). Two distinct regions are present in
the annulus ﬁbrosus (AF): the outer and the inner part,
which have quite different characteristics. In the outer
AF, long and elastic collagen ﬁbres lie parallel within each
lamella orientated at 60 to the vertical axis (Shankar
et al., 2009). The outer AF arrangements provide
resistance to tensile forces from body motions such as
twisting and bending (Kalson et al., 2008). The inner AF
is a transition zone between the highly organized outer
AF and the highly hydrated NP. The characteristics of
outer AF and NP are present in inner AF, which then
becomes a mixture of ECM components from both. The
inner AF contains lower water content compared to
NP. Moreover, inner AF is composed of layers that are
more widely spaced than those of outer AF. Regarding
mechanical properties, inner AF is more exposed to NP
hydrostatic pressures than to outer AF tensile forces.
At the cellular level, NP and AF are morpho- and
phenotypically distinct; therefore possessing dissimilar
metabolic processes. IVD is populated by different cell
phenotypes that are present in different cell numbers. NP is
composed of rounded and chondrocyte-like cells at a
density of 5 x 103 cells/mm3, whereas AF contains 9  103
cells/mm3 and possesses an elongated ﬁbroblast like
morphology (Eyre et al., 2002; Roughley, 2004; Roberts
et al., 2006a, 2006b; Kalson et al., 2008). The two cartilage
endplates act as a morphological and functional junction
zone occupying 90% of the interface between the IVD
and the vertebrae. These structures are composed mainly
of hyaline cartilage similar to articular cartilage. The
endplates serve as the main route for metabolites exchange
due to their dense capillary network. The cells that populate
these structures show a ﬁbroblast like morphology
(Weishaupt et al., 2001; Roberts et al., 2006a, 2006b;
Woods et al., 2010).
1.1. Biochemistry of the IVD
The cellular metabolism of IVDs greatly depends on the
ﬁnely balanced equilibrium assured by the action of
biomolecules such as growth factors (GF), tumour
necrosis factor (TNF), cytokines, and insulin like growth
factors families (IGF). The extracellular matrix (ECM)
of the distinct morphological IVD regions varies in
composition. There are quite signiﬁcant differences
between NP and AF ECMs. The natural IVD balance is
maintained by the action of different biomolecules
such as cytokines and GF, which are responsible for
controlling catabolic and anabolic processes. The process
of intervertebral disc degeneration (IDD) leads to an
increase in production of cytokines and matrix degrading
enzymes (metalloproteinases; MMPs), leading to a pre-
dominance of catabolism over anabolism (Roberts et al.,
2006a, 2006b; Clouet et al., 2009; Woods et al., 2010).
PGs, the glycosylated proteins that are strongly hydro-
philic and commonly found in connective tissues are
also abundant in NP. These proteins contribute to draw
signiﬁcant quantities of water into the disc. When PGs
are present, the NP ECM expands to become a hydrogel-
like structure. Several types of PGs are present in the
IVD. Aggrecan and versican are aggregated PGs largely
responsible for NP hydration. Non-aggregating PGs
such as decorin, biglycans, ﬁbromodulin, lumican, and
proglycan still do not have a well-deﬁned function. The
aggregated PGs aggrecan and versican are capable of
binding glycosaminoglycans (GAGs) to the core, playing
a role in cellular signaling. The mechanical properties of
IVD depend directly on the number of GAG molecules
linked to proteins, which in turn is directly related to the
compression-resistance that IVD can load (Kalson et al.,
2008). The protein Sox-9 (an essential regulatory gene
for chondrocyte differentiation) is also expressed in
healthy NP.
1.2. Degenerative disc diseases;
pathophysiology
Mild microscopic IVD degenerative changes can be
noticed with aging (Boos et al., 2002). In fact, it is the ﬁrst
body tissue to reveal signs of degeneration. IDD should be
considered as a multi-factorial process dependent on
genetic and environmental mechanisms. Studies on genetic
predisposition to IDD, namely on cervical and lumbar
regions, have suggested that there is a strong heritable
component associated to this degenerative process
(Sambrook et al., 1999). Most patients suffering from lower
back pain (LBP) present different pathological conditions
such as disc herniation, spinal stenosis, and myelopathy
(Walker and Anderson, 2004; Kalson et al., 2008).
The healthy IVD structure is the largest avascular organ
in the human body (Woods et al., 2010). As a result, the
supply of essential nutrients andmetabolites are dependent
on the process of diffusion. Small blood vessels can be
found in the outer region of the AF and sub-chondral
bone but they are limited to 1–2mm in depth. In a non-
pathological condition, IVD has a diminished diffusion
capacity that becomes even more reduced with aging and
degenerative processes. The mechanism by which small
molecules can penetrate into the disc is simple diffusion,
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which can compromise cell viability. However, cells are
adapted to this environment, resulting in a lowmitotic rate.
Another important issue related to the process of IDD is
the anaerobic metabolism carried out by cells. In this
respect, the relatively acidic pH from a non-pathological
IVD (pH 6.9-7.2) decreases to pH 6.1 under stress
conditions (pathological condition). Under pathological
conditions, inhibition of cell metabolism occurs, leading
to matrix deterioration. These alterations, in combination
with the poor innervations of the IVD (found only in the
surface of the outer AF), make regeneration of this
structure a real challenge (Buckwalter, 1995; Clouet
et al., 2009).
The number of large aggregates of PGs present in
the NP decreases throughout the years, contributing to a
reduction of the water-binding capacity. Consequently,
the desiccation of NP leads to the formation of clefts and
tears in the AF. The asymmetric distribution of loads
does not only affect the capacity of the disc to absorb
and dissipate compressive loads but also diminishes
the foramen dimensions, thereby leading to nerve
compression (Boos et al., 2002; Hukins, 2005).
1.3. Intrinsic healing process: current treatments
LBP can be associated with IDD, since it is present in
about 40% of patients (Luoma et al., 2000). A possible
explanation for this is related to the proximity of sur-
rounding muscles, joints or even the innervations of the
outer AF. The self-repair capacity of IVD is conﬁned only
to the vascularized regions. ECM modiﬁcations lead to
drastic effects in the overall IVD structure. This structure
is aimed to compensate the abnormal distribution of
forces when IDD occurs. Nevertheless, the IVD structure
can occasionally be subjected to inappropriate stress,
causing mechanical damage to the disc. Histological
changes at the cellular level are manifested by an increase
in cell proliferation and cell-cluster formation. Moreover,
an increase in cell death (necrosis and apoptosis) can
occur. The natural balance between anabolic and
catabolic processes is strongly affected by degeneration
(Trout et al., 1982; Gruber and Hanley, 1998; Johnson
et al., 2001).
Randomized trials of therapeutic approaches are an
option to relieve symptoms such as symptomatic medical
treatments such as non-steroidal anti-inﬂammatory drugs
(NSAIDs), paracetamol, and opioids that act as muscle
relaxants. Last resources, including the use of anti-
neuropathic drugs and invasive surgical methods are also
a possibility. Nevertheless, these treatments have limited
efﬁcacy and cost-effectiveness (Deyo and Weinstein,
2001; Richardson et al., 2007; Kalson et al., 2008;
Freimark and Czermak, 2009).
Current conservative practices for treating patients
with acute or sub-acute LBP are directed towards removing
the damaged tissue and/or stabilizing the resultant
instability by surgery. The most common spinal surgery
intervention is neurological decompression by discectomy,
a procedure where the NP that is causing pain by stressing
the spinal cord or radiating nerves is removed (Yeung and
Yeung, 2007). Consequently, the disc height cannot be
restored and the capacity to bear loads is dramatically
reduced, thereby affecting the biomechanics of the IVD.
Another surgical intervention commonly performed is bone
fusion, wherein adjacent vertebrae are fused. To promote
the growth of new bone to connect both vertebrae, bone
grafting is usually performed. Recently, the use of bone
morphogenetic protein 2 (BMP-2) in humans to promote
the anterior lumbar inter-body fusion has been approved
by the Food and Drug Administration (FDA) (Masuda,
2004). However, after bone fusion, ﬂexibility was reduced
and degenerative changes could be induced in adjacent
vertebral bodies. Partial or total disc excision also presents
serious contraindications and it has been performed
followed by posterior replacement with artiﬁcial discs.
There are no data reporting their long-term efﬁcacy (Woods
et al., 2010).Synthetic prostheses to replace IVD are now
commercially available. The total IVD structure, or part of
it, can be also removed to proceed with the insertion of
allogeneic or autogeneic tissues. Both procedures present
several difﬁculties and are thus not very feasible. In fact,
when performing such types of interventions, height is
reduced and water and PGs can also be lost. Finally yet
importantly, there is the possibility of immunogenicity but
low tissue availability could be an issue (Kalson et al.,
2008; Kandel et al., 2008). Regenerative therapies can
be divided into cell therapy, gene therapy, and tissue
engineering. More recently, approaches using functiona-
lized scaffolds showed to be a feasible therapy to restore
the IVD (Hegewald et al., 2008).
2. Biomaterials based therapies
2.1. Artiﬁcial disc: disc prosthesis
Various devices to restore normal disc height and support
loads have been extensively investigated. However, these
devices lack some requirements to be successful in IVD
restoration. Device migration, extrusion, and failure are
some of the problems that can occur, thereby making
these devices unsuitable. In addition, these types of
devices have limited life-spans in vivo and require revision
surgeries (Bao et al., 1996).
Total disc replacement could be performed using three
different artiﬁcial disc options: metallic disc replace-
ments, non-metallic materials, or a combination of both.
Metallic devices take advantage of their high fatigue
strength and of being capable to withstand loads up to
100 million constant amplitude cycles. As a result, the
devices have a life-span of 40 years. However, strategies
involving metallic replacements remain unable to replicate
the complex motion of the disc. Metallic devices
constructed from alloys (stainless steel, titanium, cobalt-
chromium) show high biocompatibility and are therefore
being used in orthopaedic surgeries. However, the growth
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of ﬁbrous tissue around the devices can compromise their
application. Additionally, the friction between the device
components can generate wear debris, leading to immune
responses and even failure of the system (Boyd and Carter,
2006; Goins et al., 2005).
Non-metallic devices are composed of polymers and
elastomers that possess mechanical similarities to the nat-
ural disc. The combination of metallic and non-metallic
devices results in a sandwiched structure composed by
metal-polymer-metal. Some strategies have focused on
developing prosthesis to restore NP that easily resembles
the IVD structure. However, in advanced stages of degen-
eration, those devices are not viable (Bao et al., 1996).
Most prosthesis applications are created immediately
after open surgery or percutaneous nucleotomy. The
prosthetic disc nucleus (PDN) is one example of these
devices and is comprised of two sections: the ﬁrst is made
up of a non-degradable hydrogel pellet (polyacrylamide)
and the second, which surrounds the hydrogel, is a
polymer mesh or jacket composed of polyethylene (Di
Martino et al., 2005). AquarelleW (StrykerW Orthopaedics,
Mahwah, NJ, USA) is another example of an implant that
is primarily composed of polyvinyl alcohol. Different
kinds of prostheses have been reported such as Newcleus
Spiral Implant, composed by a polymer with memory
and NuCore™ (SpineWave Inc., Shelton, CT, USA), a
copolymer of silk and elastin. The number of patents for
injectable biomaterials aimed for NP restoration has
increased in the last decade. In this respect, a wide range
of biomaterials have been studied including chitosan,
injectable synthetic polymers, recombinant bioelastic
materials, cross-linkable silk elastin copolymer, and
polyurethane-ﬁlled balloons (Boyd and Carter, 2006).
Prosthetic discs are not seen as a good strategy to
regenerate IVD since they lack the ability to remodel
and sustain cyclical stress (Woods et al., 2010). Such
devices require improvements in surgical techniques to
avoid implant migration. Moreover, their efﬁcacy requires
extensive further research to be validated by clinical data
(Goins et al., 2005).
2.2. Polymeric-based Designs
Many novel therapies have focused on restoring not only
the IVD structure but also its functioning. Apart from
focusing on pain suppression, new therapies should
address IVD preservation, repair, reinforcement, and
regeneration. The ultimate goal is to achieve mechanical
stability and formation of neo-tissue resembling natural
IVD over a long term. When considering the restoration
of natural IVD function, it is important to deﬁne IVD
stages of degeneration. Due to the huge number of load-
ing cycles that the spine often bears, the potential substi-
tute should be able to support signiﬁcant physical loads.
Regarding biocompatibility, the material should be able
to degrade in balance with matrix synthesis without
inducing acute immune responses or any deleterious
cytotoxic effects. The sterilization process that both
enables the preservation of original bioactivity and chem-
ical composition and avoids bacteriological contamination
appears to be a good procedure for hindering immune
responses or even infections (Boyd and Carter, 2006).
The best suited approaches may require a simple strategy
or a more intricate design such as tissue engineering that
can combine scaffolds, biomolecules, and cells, (Bron
et al., 2009; Clouet et al., 2009). Advances in the ﬁeld of
tissue engineering and regenerative medicine (TE&RM)
have been targeting the replacement or repair of injured
tissue by creating a structural and functional tissue
mimicking the native one (Slaughter et al., 2009).
New insights on IVD substitute designs have been
performed throughout the years. In the 60’s, scientists
(Nachemson and Evans, 1968) suggested the injection of
vulcanized silicone into the degenerated disc. Later,
Shneider et al. (Schneider and Oyen, 1974a, 1974b) pro-
posed the use of silicone elastomer as an IVD substitute.
Over 40 years, several IVD substitutes have been designed
to restore IVD functioning. Currently, many substitutes
have been produced by means of using synthetic, natural
materials, and blends. Due to the many similarities
between joint cartilage ECM and NP ECM, different scaf-
folds developed for joint regeneration could be an optimal
choice in IVD tissue engineering (Clouet et al., 2009).
Similarly, therapeutic strategies used in other types of
cartilage such as articular cartilage and meniscus could
also be considered for IVD regeneration. This is mainly
due to the similarities of these tissues in terms of the
harsh biologic and mechanical loading conditions (Setton
et al., 2007).
Interestingly, some studies on cartilage repair could
serve alternatively as guidelines in the design of new
strategies for IVD regeneration. Elisseeff et al. (Elisseeff
et al., 2000) encapsulated bovine and ovine chondrocytes
in a poly(ethylene oxide)-dimethacrylate and poly(ethylene
glycol) semi-interpenetrating network. The hydrogel
constructs were obtained by photopolymerization and
investigated for their mechanical properties and biological
performance. Results showed that the chondrocytes were
viable after 1 day of culturing and dispersed within the
hydrogel. Over a period of 2weeks, biochemical analysis
revealed an increase in proteoglycans and collagen, leading
to a functional ECM.
A 3D network to promote interaction between cells and
ECM is crucial for the regulation of tissue morphogenesis.
As reported elsewhere (Khetan et al., 2010), besides 3D
environment remodeling ability, an appropriate material
should be able to support cellular functions. Hyaluronic
acid (HA) has been proposed as a material possessing
such features but it has also been chemically modiﬁed
for improving its biostability. In fact, HA hydrogels have
been synthesized using multiple types of crosslinking.
Using this strategy, encapsulated mesenchymal stem cells
(MSCs) were able to spread in a controlled manner. The
spatial control could be vital for developing complex
microenvironments. As a result, the use of hydrogels in a
clinical setting presents many advantages such as the
possibility of being implanted using minimally invasive
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techniques. Besides, due to their gel-like behaviour, it is
possible to predict an efﬁcient ﬁlling of the complete
defect area, which is an advantage from a materials inte-
gration point of view. An interesting study involving
promising hydrogels has been reported by the Fan group
(Fan et al., 2010). In their study, MSCs isolated from
rabbit synovial tissue were encapsulated within Gellan
gum hydrogels (GG). The constructs were cultured
in vitro and proliferation and chondrocyte gene/protein
expression were investigated over a period of 42 days.
Results showed that the MSCs were viable and produced
cartilaginous-like matrix (collagen and GAGs). Moreover,
cells expressed chondrogenic markers such as collagen
type II, Sox-9, biglycan, and aggrecan. Approved by the
FDA, GG is a promising biomaterial when considering
tissue-engineered cartilage. The pioneering studies
performed by Oliveira et al (Oliveira et al., 2009a,
2009b; Oliveira et al., 2010) revealed that GG hydrogels
have an adequate biological performance for ﬁnding a
potential application in cartilage tissue engineering. As
reported elsewhere (Oliveira et al., 2009a, 2009b), GG
hydrogels not only allowed cell encapsulation but were
shown to support human chondrocyte viability in vivo.
Type II collagen and aggrecan were found to be expressed.
In fact, a functional cartilage tissue was formed in nude
mice after 4weeks of subcutaneous implantation. Other
interesting studies addressing IVD regeneration have been
performed to evaluate the interaction of cell biomaterial
in vitro. Unfortunately, few in vivo studies have been per-
formed to date. Table 1 summarizes different approaches
of cellular polymeric-based designs for IVD regeneration
that show promise for future clinical application.
The three main components of IVD aimed at tissue
regeneration are: 1) AF (Sato et al., 2003; Chang et al.,
2007; Helen and Gough, 2007; Nerurkar et al., 2007;
Shao and Hunter, 2007; Wan et al., 2007; Nerurkar
et al., 2008; Wang et al., 2008; Nerurkar et al., 2009); 2)
NP (Baer et al., 2001; Sakai et al., 2003; Seguin et al.,
2004; Bertram et al., 2005; Wilke et al., 2006; Roughley
et al., 2006; Cloyd et al., 2007; Chou et al., 2008; Halloran
et al., 2008; Richardson et al., 2008; Vernengo et al.,
2008; Bron et al., 2009; Chou et al., 2009; Sawamura
et al., 2009; Calderon et al., 2010; Silva-Correia et al.,
2010a; Silva-Correia et al., 2010b; Reza and Nicoll,
2010;); and 3) both NP and AF by means of using biphasic
scaffolds (Mizuno et al., 2004; Hamilton et al., 2005;
Mizuno et al., 2006; Nerurkar et al., 2008; Nesti et al.,
2008). It has been proposed that for producing a tissue
resembling natural IVD, total IVD replacement could be
required. In this respect, strategies focused on the injec-
tion of cells and biomolecules alone or in combination
have been proposed. However, when NP restoration is
considered, it might not be possible to reverse all the
IVD modiﬁcations (calciﬁcation observed in endplates),
even when using approaches involving cell/scaffold
constructs. The restoration of all AF functions is complex
to achieve. Some speciﬁc requirements are required to
validate the AF engineered scaffolds. The design should
ﬁrst not irritate or adhere to the perineurium; rather, it
should have an anisotropic behaviour and secrete the native
ECM while allowing the ﬁxation of surrounding structures.
It should also support direct mechanical strength. As a
result, the lamellar and ﬁbrocartilaginous framework of
the AF will demand a highly organized and oriented tissue
into distinct lamellae. The presence of collagen (mainly
type I) in AF makes it resistant to tensile loads. Several
strategies aimed at regenerating AF use different types of
material, processing techniques, cells source, and pheno-
types. Besides, it should be mentioned that the mechanical
properties of such implants should resemble those of the
native AF (Setton et al., 2007; Bron et al., 2009). This
explains in part why strategies for AF regeneration are
mainly focused on synthetic materials and their processing
onto porous scaffolds and electrospun nets (Sato et al.,
2003; Wan et al., 2007; Helen and Gough, 2007; Nerurkar
et al., 2007; Nerurkar et al., 2008a, 2008b; Nerurkar et al.,
2009; Chang et al., 2007; Wan et al., 2008).
Research within this ﬁeld has been limited to date to
fundamental in vitro and in vivo studies aimed to investi-
gate cell attachment, proliferation, phenotypes, and
ECM production in AF. For example, Sato et al. (Sato
et al., 2003) demonstrated that AF cells isolated from rats
retained a ﬁbrocartilaginous phenotype and produced
more ECM in 3D cultures compared to 2D (monolayer).
To obtain scaffolds with unidirectional aligned ﬁbres,
Shao et al. (Shao et al., 2007) produced wet-spinned
composite scaffolds of alginate and chitosan. The AF cells
isolated from dogs were found to survive and proliferate.
Moreover, both types of collagen (I and II) and aggrecan
were found to be synthesized after 14 days. Similarly,
Wan et al. (Wan et al., 2007) harvested AF cells from rats
and in vitro studies revealed that these cells proliferated,
leading to expression of type II collagen. The subcutaneous
implantation of these constructs showed no immunogenic
response. The degradation and tensile strength increased
with a corresponding increased time of photopolymerization.
Another study by Wan et al. (Wan et al., 2008) assessed the
possible regeneration of outer and inner parts of AF using a
biphasic construction. The outer AF was made up of bone
matrix gelatine (BMG) and the inner AF was comprised of
polycaprolactone triol malate (PPCLM). The incorporation
of BMG in PPCLM improved the compressive strength
of the construct. The outer AF structure was seeded with
chondrocytes harvested from rabbits. After 4weeks of
culturing, the chondrocytes attached to the scaffolds,
proliferated well, and migrated into the BMG. In both
structures, production of type II collagen and aggrecan
was observed over a period of 28days.
Another study (Helen et al., 2007) carried out an
in vitro study where scaffolds composed by poly DL-lactic
acid (PDDLA) and BioglassW/HDPE (at different ratios)
were processed as foams. The human cells seeded on
these foams formed clusters attached to pores of
PDDLA/30BG and PDLLA/5BG. The PDLLA/30BG foam
showed the highest amount of GAGs formation, and in
all cultures, the presence of collagen (mainly type I),
was observed. Nerurkar and coworkers (2007; 2008;
2009) performed some studies involving electrospun
Hydrogels for IVD regeneration
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polycaprolactone (PCL). Different types of cells were
seeded on the scaffolds but all of them supported cell
alignment along the ﬁbres. Biologically, GAGs and colla-
gen increased during the culture period, showing that
these scaffolds efﬁciently supported cellular functions.
2.2.1. Hydrogels in cellular strategies for disc
regeneration
Nucleus pulposus (NP). Hydrogels have been
attracting a great deal of attention in IVD regeneration
due to the possibility of developing biomaterials that
structurally resemble the ECM. A wide range of hydrogels
have been studied for their wide physical and chemical
properties. The hydrogel designs contemplate the perfor-
mance of the implants in terms of structural integrity,
biodegradability, biocompatibility, molecular response,
solute transport and cellular behaviour, mechanical
strength, and low viscosity.
Natural hydrogels are particularly appealing for such
applications, mainly due to their inherent biocompat-
ibility. However, synthetic hydrogels allow for large-scale
production and offer consistent and highly tunable
properties, which are important advantages. However,
since most synthetic procedures involve harsh reagents,
there is a need to ensure that contaminants and unreacted
reagents are completely removed (Slaughter et al., 2009).
This issue is extremely important to avoid possible
cytotoxic and immunogenic effects.
The 3D network of hydrogels makes them the best
option to allow the interaction of cells and ECM, leading
to a dynamic tissue morphogenesis (Khetan et al., 2010).
Hydrophilic polymers (co-, homo-, or macromers) are
able to be crosslinked to improve their bio-stability
in vitro and in vivo. The hydrogels are typically soft and
elastic after crosslinking (Slaughter et al., 2009). These
injectable biomaterials are most advantageous since they
allow the incorporation of cells and biomolecules alone
or in combination. The possibility of injection by a small
puncture, which can reduce the surgical damage and
allow good dispersion of cells and/or biomolecules within
the material, makes hydrogels suitable substitutes for NP.
In this respect, the NP substitutes should not only be able
to completely ﬁll the shape and size of the damage but
also be well ﬁxed in the NP space (Boyd and Carter,
2006). The ampliﬁcation of the repair process can be
enhanced through GF-, TNF-, or IGF-functionalization of
the injectable materials. As a result, injectable and func-
tionalized hydrogels that can be ionic and/or chemically
crosslinked appear to be a promising alternative for
restoring natural NP functions. Another challenge that
has been addressed concerns the mechanical properties
of NP, which is a quite soft tissue (5 kPa) due to its uncon-
ﬁned compression (Nerurkar et al., 2010). In this respect,
hydrogels are also very versatile and by varying the type
of material, molecular weight, degree of crosslinking,
chemistry, and functionalization, it could be possible to
mimic the mechanical properties of the native tissue.In
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Several strategies have been examined to replace NP
healthy functions. These are summarized in Table 1 (Baer
et al., 2001; Sakai et al., 2003; Seguin et al., 2004;
Bertram et al., 2005; Wilke et al., 2006; Roughley et al.,
2006; Cloyd et al., 2007; Chou et al., 2008; Halloran
et al., 2008; Richardson et al., 2008; Vernengo et al.,
2008; Bron et al., 2009; Chou et al., 2009; Sawamura
et al., 2009; Calderon et al., 2010; Silva-Correia et al.,
2010; Silva-Correia et al., 2010; Reza and Nicoll, 2010;).
Similarly, Baer (Baer et al., 2001) investigated the
mechanical behaviour of NP in terms of compressive and
torsional shears. Alginate hydrogels cultured with porcine
cells isolated from inner AF were maintained for 16weeks
in vitro. Posterior assessments revealed the maintenance
of NP-like phenotype. Although a decrease of shear stress
was observed, the values remained in the same order of
magnitude compared to native tissue. Another study
performed by Bron et al. (Bron et al., 2009) demonstrated
that type I collagen gels presented a lower phase angle
compared to native tissue but showed quite favourable
results concerning shear modulus. Reza and Nicoll (Reza
and Nicoll, 2010) studied different methods to obtain
photocrosslinked hydrogels by modifying carboxymethyl-
cellulose with methacrylate groups. Bovine NP cell-
encapsulated hydrogels were viable at 7 days of culturing.
Moreover, the developed hydrogels showed good values
to elastic modulus. Histological assessments showed that
cells possessed a round morphology and production of
proteoglycans was observed after 14 days of culturing.
In vivo effects of platelet-rich plasma-impregnated
gelatine hydrogels microspheres were developed to ﬁnd
applications for the treatment of IDD. Chitosan has been
proposed as a suitable cell-based scaffold (Roughley
et al., 2006). In that study, NP cells were encapsulated
in different formulations of chitosan-glycerophosphate
gels. In vitro results showed proteoglycans (PGs) produc-
tion by NP cells. These were found to be entrapped into
the hydrogels rather than released into the culture
medium. Their studies also demonstrated that water
content in such constructs was preserved. The production
of PGs core proteins assessed by mRNA synthesis was
increased compared to other constructs. Similarly, type II
collagen production also increased. However, cells in the
proliferating state were not found in NP and inner AF. A
signiﬁcant decrease in apoptotic cells in NP was observed.
A study by Calderon et al. (Calderon et al., 2010) proposed
different polymers to regenerate NP. In that study, two
types of materials, type I collagen and HA, were seeded
withMSCs.Thehydrogelsdemonstrated tobe stable in vitro.
The level of crosslinking was found to have a signiﬁcant
inﬂuence on both swelling properties and cellular
proliferation. They also evaluated the differentiation of
MSCs into chondrogenic lineage. The current study group
(Silva-Correia et al., 2010a, 2010b) has proposed the use
of novel chemically modiﬁed Gellan gum hydrogels with
the hope of ﬁnding applications for NP regeneration. The
methacrylation of Gellan gum (GG-MA) allowed the
synthesis of both ionic- and photo-crosslinkable hydrogels
for in situ geliﬁcation. Moreover, the ability of these
hydrogels to be photo-crosslinked by UV light lead to the
production of hydrogels with improved mechanical proper-
ties that ultimately could mimic NP. This in vitro study
showed that the hydrogels (GG-MA)were non-cytotoxic over
L929 cells. Since the chemical modiﬁcation GG improved the
physicochemical and biological versatilities of the hydrogels,
the produced GG-MA appeared as a suitable biomaterial to
be used in NP regeneration (Cloyd et al., 2006).
Recently, this study group (Pereira et al., 2011)
proposed a substitute to regenerate NP by means of using
Gellan gum hydrogel matrices with cell-loaded micropar-
ticles (MPs). Two forms of Gellan gum (High and Low
acyl) were combined in different ratios and processed as
matrices and MPs. The matrices were reinforced with
MPs possessing the same formulation. Mechanically, the
formulation of 25% HAGG: 75% LAGG incorporated with
MPs at 50mg/ml showed the best mechanical perfor-
mance compared to native NP. All hydrogel formulations
were tested in vitro to screen for possible cytotoxicity.
The cell culture studies revealed that the hydrogels did
not have a cytotoxic effect over L929 cells. Moreover, the
cell-loaded MPs were efﬁciently produced and L929 cells
remained viable over a period of 72 hours.
Biphasic scaffolds for AF and NP. To restore
IVD, therapeutic approaches should address not only
the anatomic aspects and mechanical behaviour of
the tissue, but primarily ensure that the natural functions
of IVD are recovered. The complex and heterogeneous
IVD needs to be well deﬁned and should be the main goal
when tissue engineering this tissue. As a result, strategies
addressing the different components of IVD structure, NP,
and AF, could be required to restore IVD functions. As
shown in Table 1, few studies have shown the efﬁcacy of
synthetic and natural polymers to regenerate AF and NP
(Mizuno et al., 2004; Hamilton et al., 2005; Mizuno et al.,
2006; Nerurkar et al., 2008; Nesti et al., 2008). However,
a study performed by Mizuno et al. (Mizuno et al., 2004)
revealed the efﬁcacy of an integrated biphasic composite
for AF and NP regeneration. The polymers used were
polyglycolic acid seeded with AF cells and alginate scaffolds
cultured with NP cells. The in vivo study was performed in
rats for 12weeks. Despite the innovative character of the
study, results showed that the implant only allowed the
synthesis of half the amount of PGs and collagen compared
to native tissue. In another integrative tissue engineering
study, Hamilton et al. (2005) developed a calciﬁed tissue
cartilaginous endplate NP. The ﬁrst approach was to
generate a hyaline cartilage tissue layer seeded with NP
cells on calcium polyphosphates substrates. The NP cells
were able to synthesize the PGs that are found in natural
discs but did not produce collagen. More research is
required to integrate all IVD structures.
Other studies (Mizuno et al., 2006; Nerurkar et al., 2008)
developed an interesting strategy to replicate the micro-
structural organization of AF by using scaffolds made of
aligned PCL nanoﬁbers. The centre of the PCL scaffold
was ﬁlled with agarose to resemble NP. The compressive
properties of agarose increased by reinforcement with the
D. R. Pereira et al.
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multilamellar PCL nanoﬁbers. The frameworks resembling
the natural ones allowed cells to adopt opposing orienta-
tions of 30. Consequently, a deposition of collagen
into multilamellar angle-ply organization was observed.
Similarly, a study performed by Nesti (Nesti et al., 2008)
consisted of coupling HA hydrogel with electrospun
nanoﬁbers of poly(L-lactic) acid (PLLA). The HA was used
to encapsulate MSCs that were injected at the centre of
the non-aligned nanoﬁbrous mesh. The nanoﬁbrous mesh
was also seeded with MSCs to produce cells possessing a
different phenotype. In the AF region, cells developed a
ﬁbroblastic like phenotype. A chondrogenic phenotype
was observed in cells encapsulated in the HA hydrogel. As
a result, that study reported the production of disc-like
tissue by means of using MSCs seeded in biphasic scaffolds.
Cell Source. The cells that were investigated to
engineer tissues can be obtained from different sources
and have different origins, namely, human and animal
(canine, ovine, bovine, rabbit). The lack of healthy human
disc cells impairs their use in tissue engineering strategies.
Some studies (Roberts et al., 2006; Gruber et al., 2007;
Le Maitre et al., 2007) reported a high degree of senes-
cence of the cells when herniated discs were the source
of the cells. Cells from discs showing degeneration may
not be an optimal source of cells for tissue engineering
strategies (Gruber et al., 1998). The isolation of cells from
healthy human IVDs raises important issues that should
be taken in account: the natural environment of cells is
signiﬁcantly changed after isolation and the removal of
tissues to isolate healthy cells can lead to IDD (Woods
et al., 2010). To deal with this drawback, cells recovered
from healthy IVDs of small animals show promise as a
feasible alternative. To obtain a sufﬁcient number of
cells for tissue engineering and regenerative medicine
(TE&RM) applications, these cells need to be ﬁrst
expanded in vitro for several weeks.
Currently, notochordal cells and MSCs have been well
investigated for their regenerative potential. Studies
involving their use in the regeneration of osteoarticular
tissue encourage researchers to explore similar cellular
strategies for IVD regeneration. These cells can differenti-
ate into different phenotypes, namely NP cells (Vernengo
et al., 2008) and chondrocytes (Merceron et al., 2008;
Vinatier et al., 2009). Richardson et al. (Richardson
et al., 2006) showed that co-cultures of normal human
NP and normal human MSCs with and without cell-cell
interaction resulted in MSCs with an NP-like phenotype.
It was shown by an increase in aggrecan and type II
collagen genes. Studies of bone marrow and adipose
tissue have also been performed. Vadala et al. (Vadala
et al., 2008) performed a study with MSCs co-cultured
with NP cells. The study revealed an altered gene proﬁle
expression and the up-regulation of ECM synthesis.
Besides MSCs, nothocordal cells have been proposed as
a good choice for use in TE&RM. These types of cells are
not produced in adult human IVDs; however some animals
express these cells over their life time. Aguiar et al. (Aguiar
et al., 1999) carried out a study involving co-cultures of
nothocordal cells with NP cells. The in vitro studies showed
an increase in PG synthesis. However, when using these
cells, the risk of tumour growth could not be discarded in
both cases and its screening should be well assessed (Sakai
et al., 2008).
To efﬁciently regenerate injured tissues, the cells seeded
into the materials should demonstrate characteristics
similar to those found in normal tissues. As a result, cells
cultured in vitro often require the presence of speciﬁc
morphogenetic factors. The characteristic phenotype of
each cell type can be maintained by mean of culturing in a
3D environment (Benya and Shaffer, 1982; Vinatier et al.,
2005). The vast amount of research efforts on cartilage
tissue engineering will certainly improve knowledge in this
ﬁeld and hopefully will be applied in IVD TE&RM (Clouet
et al., 2009). Chou et al. (Chou et al., 2006) reported the
negative effect of cell cultures of inner and outer AF in
2D. That study showed that cells lost their phenotype up
to passage two. In later stages, both types of cells became
indistinguishable. Reza et al. (Reza and Nicoll, 2008)
showed that cells from inner and outer AF were able to
express collagen type II when seeded in poly-glycolic acid
(PGA) scaffolds and cultured under hydrostatic pressure.
The scaffolds seeded with outer AF cells expressed a more
pronounced and organized ECM. However, it was reported
that cells were able to express mainly collagen type I in vivo
(Bron et al., 2009). As a result, further studies are required
to develop adequate TE&RM strategies for obtaining the
production of a native-like ECM.
2.2.2. Hydrogels in acellular strategies for disc
regeneration
Cell-free scaffolds have also been investigated for their
potential as IVD substitutes. The advantages of these
substitutes are mainly associated with mechanically stabil-
ity and present less shipping constraints and longer shelf
life compared to cell-based scaffolds (Woods et al., 2010).
As reported by Abbushi et al. (2008) and Endres et al.
(2010), implantation of PGA-HA scaffolds, which have been
shown to be suitable for proteoglycans-rich tissues, induces
the regeneration of NP. The migration of cells into the
defect area is responsible for the increase of the amount
of PGs within a period of 12months. To produce cell-free
scaffolds capable to restore the IVD, Waldman et al. (2002)
and Seguin et al. (2004) showed that calcium phosphates
ould be used as substrates to engineer NP and endplates
in vitro. The success of this strategy relies on the similarity
to native tissue; once the PGs are being synthesized and the
biomechanical properties closely resemble the natural ones.
Biomolecules to functionalize hydrogels. Scaffold
performance can be improved by functionalization of
the biomaterial. The capacity of polymers to bind or be
linked to biomolecules has been attracting a great deal
of attention in IVD regenerative strategies. To recruit
and protect growth factors such as bone morphogenetic
proteins (BMPs), basic ﬁbroblastic growth factors (bFGFs)
and vascular endothelial growth factors (VEGFs), heparin
Hydrogels for IVD regeneration
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functionalization has been explored by several authors
(Nie and Wang, 2007; Joung et al., 2008). Heparin functio-
nalization could be a good strategy due to its ability to bind
to biomolecules. In this way, a wide range of methods have
been developed towards functionalized scaffolds with
heparin (Fugita et al., 2004). Hydrogel constructs functio-
nalized with heparin and ﬂuvastin have also been proposed
for bone repair. Benoit (Benoit et al., 2007) showed that
the developed scaffolds were able to promote osteogenic
differentiation of human MSCs. Similarly, Edlund et al.
(2008) reported that BMP-2 loaded in heparin functiona-
lized polymers improved adhesion and proliferation of
murine MSCs. Another study (Fujita et al., 2004) showed
that biologically active FGF-2 was stimulated by chitosan/
periodate-oxidized (IO4) heparin hydrogels. The studies
reported by Fujita and Edlund (Fujita et al., 2004; Edlund
et al., 2008) showed that functionalized materials are
effective in promoting IVD regeneration. Covalent linking
of heparin to scaffolds has been described as the most
attractive method to functionalize materials (Yang and Li,
2009). Nevertheless, a novel approach to design scaffolds
by heparin carrying microcapsules was reported by Li
et al. (2009). The microcapsules were grafted to the
material, which ensured minimal loss of bioactivity and
kept the heparin molecules intact.
Chang et al. (2007) developed a strategy to improve cell
attachment on the silk porous scaffolds by chemical
bonding to the RGD, an integrin binding motif. The study
showed that improvement of cell adhesion was not
achieved but that collagen type II and aggrecan produc-
tion increased. However, the increase of collagen type II
and aggrecan observed was not suitable for the regenera-
tion of AF since collagen type II is not able to form or
bundle ﬁbrillated structures. Therefore, the use of biomo-
lecules such as decorin or small PGs could be addressed
when functionalization of biomaterials is considered.
These biomolecules are known to be capable to bind
TGF-b and have increasingly been used in fundamental
studies (Macri et al., 2007).
3. Direct injected-based therapies
3.1. Cell therapy
The continuous investigation of IVD biology and its
degenerative cascades has created novel concepts for
developing functional solutions at a cellular level (Woods
et al., 2010). Frequently, IDD appears at an early age,
especially during the second decade of life. The abnormal
cell-mediated response leads to injuries at the cellular
level (Woods et al., 2010). As a result, it has been
proposed to use of cellular strategies to efﬁciently regen-
erate IVD. The reinsertion of autologous cells can limit
the application of cell therapies. Human IVD lacks in
nothocordal cells and differentiated cells harvested from
degenerated IVDs show an altered phenotype impairing
their use in clinics. Moreover, surgical procedures to
harvest cells can induce degeneration in healthy discs.
Degenerated discs show cells possessing different pheno-
types due to altered biochemical processes, which lead
to increased rates of senescent cells. The clinical applica-
tion of such cells can induce a degenerative cascade of
the IVD. The regeneration of the IVD by reinsertion of
allogeneic cells poses the risks of immune rejection,
allergy, or disease transmission. Despite being non-vascular
and non-innervated, IVD pathological conditions are associ-
ated with an increase in neovascularization and innerva-
tions. Stem cells lack the speciﬁc markers responsible for
determining the cell lineage (Woods et al., 2010). As a
result, stem cells could be excellent candidates to repair
IVD when considering the use of cellular approaches. In a
study reported by Sobajima et al. (Sobajima et al., 2008),
human mesenchymal stem cells (hMSCs) were co-cultured
with human nucleus pulposus cells (hNPCs) to assess the
feasibility of stem cells in restoring IVD. The transplanted
stem cells showed excellent viability and migration
through different IVD structures and differentiated in
several phenotypes. However, some speciﬁc markers were
not expressed in the used cell type. The presence of
molecules such as aggrecan, collagen type II, and SOX-9
allows us to distinguish the IVD cells. However, these
markers are non-speciﬁc and are also used to identify
articular chondrocytes, for example (Risbud et al., 2004).
3.2. Biomolecules therapy
One approach to stimulate IVD regeneration is based on
the direct injection of biomolecules acting as activators
for ECM production. IVD cells are differently inﬂuenced
by several growth factors and enzymes, which can be
injected as pure protein solutions or combined with
matrices that allow their controlled release. Most studies
involving the use of BMPs in IVD were aimed at stimulat-
ing ECM production (Zhang et al., 2007). In the study
reported by Zhang et al. (Zhang et al., 2007), AF cells
were stimulated with different BMPs and by Sox-9 trans-
fection studies. The collagen synthesis was increased by
over-expression of such molecules. Interestingly, another
study (Takegami et al., 2005) reported the repair of
ECM by stimulation of AF cells with OP-1 (also known
as BMP-7). Masuda et al. study (Masuda et al., 2003)
showed a signiﬁcant increase in total DNA, PG synthesis,
and collagen content by continuous stimulation of AF cells
with BMP-7. In addition, the study was able to establish
the best performance of BMP-7 on NP compared to AF
results. Currently, BMP-7 is widely used in studies related
to bone and cartilage tissue engineering. The chondrocyte
differentiation results in a stimulation of matrix produc-
tion, mainly PGs and collagen type II (Kong et al.,
2008). BMP-2 has been shown to exert potent effects both
in articular chondrocyte ingrowth capacity and anabolic
processes. Although, some in vivo studies showed an
increase of IVD degeneration in rats treated with BMPs
(Huang et al., 2007).
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Recently, some studies proposed the use of platelet-rich
plasma (PRP) to stimulate cell proliferation and ECM
metabolism of the IVD cells. The activated platelets were
able to release multiple growth factors directly involved
in regulation of cell proliferation, differentiation, and
morphogenesis. Akeda et al. (Akeda et al., 2006) showed
the effect of using PRP in stimulating cell proliferation
and ECM metabolism. PRP cultured in alginate beads
up-regulated PGs and collagen syntheses, while accumu-
lated PG amounts were higher compared to platelet-poor
plasma. In other studies, Nagae et al. (Nagae et al.,
2007) and Sawamura et al. (Sawamura et al., 2009) inves-
tigated the in vivo effect of PRP-impregnated gelatin
hydrogel microspheres (PRP-GHM). Both studies presented
a signiﬁcant suppression of the progression of IVD degener-
ation. Similarly, Nagae et al. (Nagae et al. 2007) proposed a
different strategy in which PRP was injected directly into
the NP of degenerated IVD, instead of being impregnated
into gelatin hydrogel microspheres. The progressive
degeneration of the IVD was suppressed over 8weeks of
PRP administration. Sawamura et al. (Sawamura et al.,
2009) reported an increase of IVD height after treatment
with PRP-GHM. The presence of water was also preserved
in PRP-GHM administration. Moreover, the mRNA
expression of PGs core protein and type II collagen
increased after treatment with PRP-GHM. Although no
proliferating cells were found in the IVDs treated with
PRP-GHM, there was a decrease in the number of apoptotic
cells in the NP. However, the lack of studies in animals or
humans does not make this approach feasible yet. The
regeneration of IVD by direct injection of biomolecules is
limited since it is only of short-term action. This option
could be feasible only for mild or moderate degenerated
discs (Freimark and Czermak, 2009).
3.3. Gene therapy
Gene expression proﬁles can be changed by means of gene
therapy. To envisage a long-term stimulation of the disc,
activators can be introduced into the IVD cells genome.
Two main methods are commonly used (Kalson et al.,
2008). The in vivo method uses exogenous therapeutic
genes to target cells throughout injectable vectors. In
the ex vivo method, the targeted cells are removed and
expansion of the cells is performed in vitro and only then
are re-implanted. The second method is preferred and it
involves a virus or a non-viral carrier that aims to serve as
vehicle to integrate the gene of the activator (Freimark
and Czermak, 2009). However, adenoviruses can induce
strong immune reactions in vivo. To diminish such a
response, it has been proposed to use adeno-associated
viral vectors. Such strategies have shown positive results.
The synergistic effect of using adeno-mediated therapies
might be helpful in restoring the IVD functions.
An experiment carried out for 6weeks in a IVDs mouse
model (Nishida et al.,1999) demonstrated that gene
transfection of TGF-b had a two-fold increase in PG
synthesis. A considerable increase of PGs and TGF-b were
present during the experimental period. The successful
integration of genes of BMP-2 and IGF-1 by adenovirus
vector has also been reported in vitro (Wallach et al.,
2003; Moon et al., 2008). Both studies revealed an
increase in the synthesis of intradiscal PGs in a dose-
dependent manner. Nevertheless, the paucity of studies
focusing on the unlimited and uncontrolled release of
biomolecules makes gene therapy approaches question-
able (Freimark and Czermak, 2009). Many issues are
raised: namely, the choice of the vector, method and
timing of delivery, course of action, safety of gene transfer,
and therapeutic gene biology. An interesting study
(Grunhagen et al., 2006) reported a contraindication of
this therapy, suggesting a potential degeneration effect
due to the increase of cellular metabolism in a harsh
environment. However, gene therapy has been proposed
as an alternative to large surgical interventions (Woods
et al., 2010).
4. Future outlooks
Over the past two decades, signiﬁcant efforts have been
made to develop novel regenerative strategies targeted to
IVD. The important socio-economical impacts of LBP in
society became a serious problem with large annual
expenses. Human disability and suffering are uncomfort-
able conditions and current treatments cannot solve these
problematic on a long-term basis. The stage of IVD damage
should be accurately assessed in order to design the most
suitable substitute(s). Many problems are continuously
emerging while strategies to restore/regenerate IDD are
under development. The pathological state as cause of
degeneration is not well deﬁned. A considerable knowl-
edge achieved in cartilage tissue repair is nowadays used
for IVD restoration. However, the high complexity and
heterogeneity of IVD require an increase in the fundamen-
tal knowledge to understand all processes involved in IVD
degeneration. To be feasible, an IVD regenerative strategy
should require integration among native tissues and
generation of functional neo-tissue. Therapies using cells,
biomaterials, biomolecules, or gene therapy by direct
injection are performed as standalone therapies. Neverthe-
less, the short-term success and the unclear long-term
consequences become a pitfall. Meanwhile, such strategies
are used to restore a single tissue. Novel approaches are
being studied focusing on restoration of two dissimilar
tissues, the AF and NP. All approaches involve the use
of cells/biomolecules/genes alone or combined with
biomaterials, mainly hydrogels. Signiﬁcant research should
be conducted to clarify both common and speciﬁc cellular
responses in human IVD. Autologous cells and growth
factors have shown great promise for developing a new
generation of biological-based therapies. Mimicking the
natural environment outside the body can be a huge
challenge in some ﬁelds of engineering, especially those
focusing on replicating the in vivo mechanical stimuli.
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Regenerative therapies can only succeed if guided by a
clear vision of their future clinical applications. To efﬁ-
ciently translate TE&RM strategies into clinical practice,
scientists should perform in vivo studies using an appro-
priate animal model. Animal IDD can occur spontaneously
or in an induced way; but by proceeding with the latter,
the experiments could be compromised. When animal
IVD is punctured to induce IDD, the pathological condi-
tion can rise up intensively after the procedure. Different
species exhibit different biochemistry and biological beha-
viours. The unclear knowledge about such features in ani-
mals can result in erroneous conclusions. Inferring the
data obtained in animals to humans is also a difﬁcult task.
The most used animals in the in vitro studies involve rat,
rabbit, and sheep models. Similarly to humans, rabbits
lose their nothocordal cells and due to their anatomic po-
sition, resemblance makes them a suitable model for
in vivo studies. Despite these pitfalls, TE&RM provides
hope to IVD and a consensus on which strategies could
be developed to treat LBP might not be too far.
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